The Technical Analyst
Healthequity Inc [HQY]
Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
Healthequity Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
1.30% $80.89
America/New_York / 19 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 6 969.37 mill |
| EPS: | 0.640 |
| P/E: | 126.39 |
| Earnings Date: | Jun 03, 2024 |
| SharesOutstanding: | 86.16 mill |
| Avg Daily Volume: | 0.571 mill |
| RATING 2024-04-19 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 126.39 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 126.39 | industry: PE -4.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$63.08 (-22.02%) $-17.81 |
| Date: 2024-04-20 |
| Expected Trading Range (DAY) |
|---|
|
$ 78.82 - 82.96 ( +/- 2.56%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-03 | Rosner Elimelech | Sell | 3 209 | Common Stock |
| 2024-04-03 | Neeleman Stephen | Sell | 1 984 | Common Stock |
| 2024-04-03 | Ladd Delano | Sell | 1 684 | Common Stock |
| 2024-04-01 | Kessler Jon | Sell | 53 295 | Common Stock |
| 2024-04-01 | Ladd Delano | Sell | 3 461 | Common Stock |
| INSIDER POWER |
|---|
| -8.65 |
| Last 99 transactions |
| Buy: 483 047 | Sell: 618 707 |
Forecast:
16:00 - $80.86
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $80.86
Forecast 2: 16:00 - $80.86
Forecast 3: 16:00 - $80.86
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $80.89 (1.30% ) |
| Volume | 0.556 mill |
| Avg. Vol. | 0.571 mill |
| % of Avg. Vol | 97.46 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For HQY
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $78.08 | N/A | Active |
|---|
HQY
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.
Latest Press Releases
2024-04-04 09:05:00 - Press Release
Benefits Leaders Believe In Power Of Ai, Considering Data Privacy And Accuracy
New study indicates that benefits professionals are in an ‘early adopter' stage with ai new study indicates that benefits professionals are in an ‘early adopter' stage with ai
2024-03-19 16:01:00 - Press Release
Healthequity Reports Fiscal Year And Fourth Quarter Ended January 31, 2024 Financial Results
Highlights of the fiscal year include: revenue of $999.6 million, an increase of 16% compared to $861.7 million in fy23. net income of $55.7 million, compared to net loss of $26.1 million in fy23, with non-gaap net income of $195.5 million, compared to $114.5 million in fy23.
2024-03-05 16:01:00 - Press Release
Healthequity Sets Date To Announce Fiscal Year End Results
Draper, utah, march 05, 2024 (globe newswire) -- healthequity, inc. (nasdaq: hqy) (“healthequity” or the “company”), the nation's largest health savings account (“hsa") custodian, today announced plans to release its fourth quarter and fiscal year end 2024 financial results following the close of regular stock market trading hours on tuesday, march 19, 2024. following the news release, healthequity management plans to host a conference call for investors on tuesday, march 19, 2024, at 4:30 p.m. et during which management will review the company's financial results.
2024-02-21 16:01:00 - Press Release
Healthequity Reports Year-end Sales Metrics
Draper, utah, feb. 21, 2024 (globe newswire) -- healthequity, inc. (nasdaq: hqy) ("healthequity" or the "company"), the nation's largest health savings account ("hsa") custodian, today announced hsas, hsa assets and total accounts as of its fiscal year ended january 31, 2024. the company also updated its previously announced fy24 guidance, affirmed its fy25 guidance, provided an updated hsa cash repricing schedule, and provided information about its upcoming investor day conference.
2024-01-08 09:00:00 - Press Release
Healthequity Announces Year-end Hsa Sales Outlook; presentation At J.p. Morgan Healthcare Conference; Investor Day
Draper, utah, jan. 08, 2024 (globe newswire) -- healthequity, inc. (nasdaq: hqy) (“healthequity” or the “company”), the nation's largest health savings account (“hsa") custodian, today announced estimates of hsas, hsa assets and total accounts for its fiscal year ending january 31, 2024, reflecting a strong sales year with new hsas and custodial asset growth.
Latest News
2024-03-20 12:36:08 - Zacks Investment Research
HealthEquity (HQY) Q4 Earnings Surpass Estimates, Margins Up
HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in the majority of its segments, in the fourth quarter of fiscal 2024.
2024-03-19 19:01:04 - Zacks Investment Research
Compared to Estimates, HealthEquity (HQY) Q4 Earnings: A Look at Key Metrics
The headline numbers for HealthEquity (HQY) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
2024-03-19 18:16:03 - Zacks Investment Research
HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates
HealthEquity (HQY) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.37 per share a year ago.
2024-03-19 11:16:15 - Zacks Investment Research
Here's Why You Should Retain HealthEquity (HQY) Stock Now
2024-03-18 10:56:15 - Zacks Investment Research
Here's Why HealthEquity (HQY) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2024-03-14 10:16:12 - Zacks Investment Research
What Analyst Projections for Key Metrics Reveal About HealthEquity (HQY) Q4 Earnings
Evaluate the expected performance of HealthEquity (HQY) for the quarter ended January 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
2024-03-14 09:40:17 - Zacks Investment Research
Should You Buy HealthEquity (HQY) Ahead of Earnings?
HealthEquity (HQY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
2024-03-12 11:00:21 - Zacks Investment Research
HealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings Growth
HealthEquity (HQY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2024-03-01 10:56:19 - Zacks Investment Research
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2024-02-27 13:11:05 - Zacks Investment Research
Why HealthEquity (HQY) is Poised to Beat Earnings Estimates Again
HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.